Definity
Payments companies reported to CMS as associated with Definity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Definity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Definity
These are the largest totals companies reported as associated with Definity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eyal Herzog | New York, NY | Cardiovascular Disease | $231,549.42 |
| Steven Mottl | Tucson, AZ | Cardiovascular Disease | $182,595.59 |
| Robert Fowles | Salt Lake City, UT | Cardiovascular Disease | $89,891.83 |
| Robert Biederman | Charleston, SC | Cardiovascular Disease | $89,351.79 |
| Kristina Gibson | Murray, UT | Acute Care (Nurse Practitioner) | $82,420.38 |
| Paul Bhella | Grapevine, TX | Cardiovascular Disease | $59,365.21 |
| Rajesh Janardhanan | Tucson, AZ | Internal Medicine | $43,485.43 |
| Rafel Rieves | Washington, DC | $35,670.00 | |
| Frederman Concepcion | Chicago, IL | Cardiovascular Disease | $33,811.56 |
| Martin Goldman | New York, NY | Cardiovascular Disease | $28,118.67 |
Prescribed Definity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.